Takotsubo Syndrome and Air Pollution
Launched by FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS · Feb 7, 2023
Trial Information
Current as of November 13, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the relationship between Takotsubo Syndrome (TTS) and air pollution. TTS is a condition that can cause sudden heart problems, often triggered by extreme stress or serious illness, and can mimic a heart attack. Researchers want to understand if exposure to air pollution makes TTS worse or increases the chances of developing it.
To participate in this trial, you need to be at least 18 years old and have been diagnosed with TTS. You also need to have information about your exposure to air pollutants. If you join the study, you can expect to provide consent for your data to be used while helping researchers learn more about how air pollution affects heart health. This trial is currently recruiting participants of all genders, and your involvement could contribute to important findings that may help improve treatment for TTS in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥18 years.
- • Diagnosis of TTS.
- • Available data for short-term and/or long-term exposure to air pollutants (see below).
- • Written informed consent to participate.
- Exclusion Criteria:
- • Age \<18 years.
- • Not available data for short-term and/or long-term exposure to air pollutants.
About Fondazione Policlinico Universitario Agostino Gemelli Irccs
Fondazione Policlinico Universitario Agostino Gemelli IRCCS is a leading research and healthcare institution based in Rome, Italy, renowned for its commitment to advancing medical science and improving patient care. As a prominent academic medical center affiliated with the Catholic University of the Sacred Heart, it integrates clinical practice, education, and research, fostering innovation in various fields of medicine. The foundation conducts a wide range of clinical trials aimed at developing new therapies and enhancing treatment protocols, with a focus on translational research that bridges the gap between laboratory discoveries and patient care. Its multidisciplinary approach and dedication to high ethical standards position it as a key player in the landscape of clinical research and healthcare improvement in Italy and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rome, Italy
Patients applied
Trial Officials
Rocco A Montone, MD, PhD
Principal Investigator
Fondazione Policlinico Universitario A. Gemelli, IRCCS
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials